首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Molecular and cellular adaptations to exercise training in skeletal muscle from cancer patients treated with chemotherapy
【24h】

Molecular and cellular adaptations to exercise training in skeletal muscle from cancer patients treated with chemotherapy

机译:分子和细胞适应在化疗治疗癌症患者的骨骼肌中运动训练

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundA growing body of evidence suggests that exercise training has beneficial effects in cancer patients. The aim of the present study was to investigate the molecular basis underlying these beneficial effects in skeletal muscle from cancer patients.MethodsWe investigated expression of selected proteins involved in cellular processes known to orchestrate adaptation to exercise training by western blot. Skeletal muscle biopsies were sampled from ten cancer patients before and after 4-7weeks of ongoing chemotherapy, and subsequently after 10weeks of continued chemotherapy in combination with exercise training. Biopsies from ten healthy matched subjects served as reference.ResultsThe expression of the insulin-regulated glucose transporter, GLUT4, increased during chemotherapy and continued to increase during exercise training. A similar trend was observed for ACC, a key enzyme in the biosynthesis and oxidation of fatty acids, but we did not observe any changes in other regulators of substrate metabolism (AMPK and PDH) or mitochondrial proteins (Cyt-C, COX-IV, SDHA, and VDAC). Markers of proteasomal proteolysis (MURF1 and ATROGIN-1) decreased during chemotherapy, but did not change further during chemotherapy combined with exercise training. A similar pattern was observed for autophagy-related proteins such as ATG5, p62, and pULK1 Ser(757), but not ULK1 and LC3BII/LC3BI. Phosphorylation of FOXO3a at Ser(318/321) did not change during chemotherapy, but decreased during exercise training. This could suggest that FOXO3a-mediated transcriptional regulation of MURF1 and ATROGIN-1 serves as a mechanism by which exercise training maintains proteolytic systems in skeletal muscle in cancer patients. Phosphorylation of proteins that regulate protein synthesis (mTOR at Ser(2448) and 4EBP1 at Thr(37/46)) increased during chemotherapy and leveled off during exercise training. Finally, chemotherapy tended to increase the number of satellite cells in type 1 fibers, without any further change during chemotherapy and exercise training. Conversely, the number of satellite cells in type 2 fibers did not change during chemotherapy, but increased during chemotherapy combined with exercise training.ConclusionsMolecular signaling cascades involved in exercise training are disturbed during cancer and chemotherapy, and exercise training may prevent further disruption of these pathways.Trial registrationThe study was approved by the local Scientific Ethics Committee of the Central Denmark Region (Project ID: M-2014-15-14; date of approval: 01/27/2014) and the Danish Data Protection Agency (case number 2007-58-0010; date of approval: 01/28/2015). The trial was registered at http//www.clinicaltrials.gov (registration number: NCT02192216; date of registration 07/17-2014).
机译:背景生长的证据表明,运动培训对癌症患者具有有益作用。本研究的目的是探讨癌症患者骨骼肌中这些有益效果的分子基础。乙二醇调查了所谓的细胞过程中所涉及的蛋白质的表达,以协调患者通过Western印迹进行运动培训。在持续的化疗中4-7周之前和之后的十次癌症患者中取样骨骼肌活检,随后与运动训练结合的持续化疗后10周后。来自十个健康的匹配受试者的活组织检查作为参考。在化疗期间,胰岛素调节葡萄糖转运蛋白的表达增加,在运动训练期间继续增加。 ACC观察到类似的趋势,一种脂肪酸生物合成和氧化的关键酶,但我们没有观察到底物代谢(AMPK和PDH)或线粒体蛋白的其他调节剂(Cyt-C,Cox-IV, SDHA和VDAC)。在化疗期间,蛋白酶体蛋白水解(Murf1和Atrogin-1)的标记减少,但在化疗结合运动训练期间没有进一步改变。观察到与自噬相关蛋白质的类似模式,例如ATG5,P62和Pulk1 Ser(757),但不是Ulk1和LC3BII / LC3Bi。在Ser(318/321)的FoxO3a磷酸化在化疗期间没有改变,但在运动训练期间减少。这可能表明FOXO3A介导的Murf1和Atrogin-1的转录调节用作患有癌症患者骨骼肌中蛋白水解系统的机制。在化疗期间,调节​​蛋白质合成(Ser(2448)的MTOR(37/46)和4EBP1的MTOR的磷酸化,在运动训练期间调节。最后,化疗倾向于增加1型纤维卫星细胞的数量,而在化疗和运动训练期间没有任何进一步的变化。相反,2型纤维中的卫星细胞数量在化疗期间没有改变,但在化疗过程中增加,与运动训练相结合。在癌症和化疗期间涉及运动训练中涉及运动训练的分子信号级联,并且运动训练可能会导致这些途径进一步破坏这些途径.trial注册学习由丹麦中部地区当地科学伦理委员会批准(项目ID:M-2014-15-14;批准日期:01/27/2014)和丹麦数据保护局(案件编号2007- 58-0010;批准日期:01/28/2015)。该试验在http // www.clinicaltrials.gov注册(注册号:NCT02192216;注册日期07/17-2014)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号